期刊
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
卷 204, 期 -, 页码 540-554出版社
ELSEVIER
DOI: 10.1016/j.ijbiomac.2022.02.039
关键词
Chitosan; Curcumin; Functionalized nanosystems; H. pylori; Nanomedicines; Resistant biofilms
资金
- Higher Education Commission (HEC) , Pakistan [5378]
- National Research Program for Univer-sities (NRPU)
In this study, the covalent modification of chitosan with curcumin was achieved to develop curcumin-functionalized chitosan nanosystems (Cur-FCNS), which showed synergistic anti-H. pylori activity and improved stability under simulated gastric conditions. The results affirmed the exceptional potential of Cur-FCNS as a next-generation alternative medicine to treat resistant H. pylori.
With the apparent stagnation in the antibiotic discovery and the propagation of multidrug resistance, Helicobacter pylori associated gastric infections are hard to eradicate. In pursuance of alternative medicines, in this study, covalent modification of chitosan (CS) polymer with curcumin (Cur) was accomplished. Proton Nuclear Magnetic Resonance and Fourier Transform Infrared spectroscopy elucidated the covalent interaction between Cur and CS with characteristic peak of imine functional group (-C=N-). Scanning Electron Microscopy provided visual proof for surface topology, while size and zeta potential values further affirmed the development of curcumin functionalized chitosan nanosystems (Cur-FCNS). The complexation efficiency of CS with Cur was found as 70 +/- 3% at an optimal ratio of 5:1 for CS and Cur, respectively. Cur-FCNS developed with ionic gelation and ultra-sonication method demonstrated synergistic anti-H. pylori activity in growth-kinetics and anti-biofilm assays, which was superior to free Cur and even chitosan nanosystems. Under simulated gastric conditions, Cur-FCNS revealed cumulative-release of only 16 +/- 0.8% till 40 h, which indicated its improved stability to interact with H. pylori. In silico findings affirmed high binding affinity of Cur-FCNS with multiple bacterial virulence factors. Thus, our results affirmed the exceptional potential of Cur-FCNS as next-generation alternative-medicine to treat resistant H. pylori.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据